Literature DB >> 11495259

Tuberculosis in a prison population in Mwanza, Tanzania (1994-1997).

E Rutta1, D Mutasingwa, S Ngallaba, A Mwansasu.   

Abstract

SETTING: Bugando Medical Centre, a referral consultant hospital in the lake zone to which all inmates from Butimba prison are admitted and treated.
OBJECTIVE: To determine the extent of open (smear-positive) tuberculosis and other types of tuberculosis among prisoners with tuberculosis.
DESIGN: A retrospective cohort study. Case notes of 501 prisoners from January 1994 to December 1997 were retrieved and reviewed.
RESULTS: The proportion of open tuberculosis in this study was high, with 204 prisoners (40.7%) having smear-positive tuberculosis. Co-infection was recorded in the majority of patients; HIV/AIDS was recorded in 25.9% of cases. The mean length of imprisonment at the time of diagnosis was 19 months.
CONCLUSION: The proportion of open, smear-positive tuberculosis among prisoners admitted with tuberculosis is high. Intervention measures specifically targeting this population are urgently needed in order to contain tuberculosis disease in the prison population.

Entities:  

Mesh:

Year:  2001        PMID: 11495259

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

1.  Screening for pulmonary tuberculosis in a Tanzanian prison and computer-aided interpretation of chest X-rays.

Authors:  A Steiner; C Mangu; J van den Hombergh; H van Deutekom; B van Ginneken; P Clowes; F Mhimbira; S Mfinanga; A Rachow; K Reither; M Hoelscher
Journal:  Public Health Action       Date:  2015-12-21

2.  High utility of active tuberculosis case finding in an Ethiopian prison.

Authors:  Y Merid; Y Woldeamanuel; M Abebe; D G Datiko; T Hailu; G Habtamu; G Assefa; R R Kempker; H M Blumberg; A Aseffa
Journal:  Int J Tuberc Lung Dis       Date:  2018-05-01       Impact factor: 2.373

Review 3.  Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic.

Authors:  F Biadglegne; A C Rodloff; U Sack
Journal:  Epidemiol Infect       Date:  2014-11-07       Impact factor: 4.434

4.  Determinants of Pulmonary Tuberculosis among Inmates at Mangaung Maximum Correctional Facility in Bloemfontein, South Africa.

Authors:  Peter Nyasulu; Serame Mogoere; Teye Umanah; Geoffrey Setswe
Journal:  Tuberc Res Treat       Date:  2015-03-17

5.  Half of Pulmonary Tuberculosis Cases Were Left Undiagnosed in Prisons of the Tigray Region of Ethiopia: Implications for Tuberculosis Control.

Authors:  Kelemework Adane; Mark Spigt; Semaw Ferede; Tsehaye Asmelash; Markos Abebe; Geert-Jan Dinant
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

Review 6.  Prisoners co-infected with tuberculosis and HIV: a systematic review.

Authors:  Chantal L Edge; Emma J King; Kate Dolan; Martin McKee
Journal:  J Int AIDS Soc       Date:  2016-11-15       Impact factor: 5.396

7.  One-fourth of the prisoners are underweight in Northern Ethiopia: a cross-sectional study.

Authors:  Semaw Ferede Abera; Kelemework Adane
Journal:  BMC Public Health       Date:  2017-05-15       Impact factor: 3.295

8.  Prevalence of smear positive pulmonary tuberculosis among prisoners in North Gondar Zone Prison, northwest Ethiopia.

Authors:  Beyene Moges; Bemnet Amare; Fanaye Asfaw; Wogahta Tesfaye; Moges Tiruneh; Yeshambel Belyhun; Andargachew Mulu; Afework Kassu
Journal:  BMC Infect Dis       Date:  2012-12-15       Impact factor: 3.090

9.  The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a large Zambian prison: a public health alert.

Authors:  German Henostroza; Stephanie M Topp; Sisa Hatwiinda; Katie R Maggard; Winifreda Phiri; Jennifer B Harris; Annika Krüüner; Nathan Kapata; Helen Ayles; Chisela Chileshe; Stewart E Reid
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  Smear positive pulmonary tuberculosis and HIV co-infection in prison settings of North Gondar Zone, Northwest Ethiopia.

Authors:  Teklay Gebrecherkos; Baye Gelaw; Belay Tessema
Journal:  BMC Public Health       Date:  2016-10-18       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.